Literature DB >> 29166517

Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.

Luanna da Silva Brito Léda1, Maria do Socorro Ventura Silva Lins1, Everson José Dos Santos Leite1, Alberto Eduardo Cox Cardoso1, Ricardo Luis Simões Houly2.   

Abstract

Syringocystadenoma papilliferum and tubular apocrine adenoma are rare benign sweat gland tumors. Syringocystadenoma papilliferum occurs alone or in association with other tumors. Although it is rare, the association of tubular apocrine adenoma with syringocystadenoma papilliferum developing in a sebaceous nevus on the scalp is well documented. However, the co-existence of these two tumors without the background of a sebaceous nevus has not been frequently reported. Syringocystadenoma papilliferum and tubular apocrine adenoma may have a histopathological overlap, but a few cases of a syringocystadenoma papilliferum combined with a tubular apocrine adenoma have been reported. Herein we describe an unusual case of syringocystadenoma papilliferum co-existing with a tubular apocrine adenoma located on the back of a 14-year-old patient in the absence of a pre-existing sebaceous nevus.

Entities:  

Mesh:

Year:  2017        PMID: 29166517      PMCID: PMC5674711          DOI: 10.1590/abd1806-4841.20174580

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  6 in total

1.  Syringocystadenoma Papilliferum in Co-existence with Tubular Apocrine Adenoma on the Calf.

Authors:  Jung Hee Yoon; Hyo Hyun Ahn; Young Chul Kye; Soo Hong Seo
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

2.  Syringocystadenoma papilliferum of the back combined with a tubular apocrine adenoma.

Authors:  Hyun Joo Lee; Eujin Cho; Min Ho Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

3.  Tubular apocrine adenoma.

Authors:  J Toribio; A Zulaica; C Peteiro
Journal:  J Cutan Pathol       Date:  1987-04       Impact factor: 1.587

Review 4.  Is tubular apocrine adenoma a distinct clinical entity?

Authors:  A Ishiko; H Shimizu; N Inamoto; K Nakmura
Journal:  Am J Dermatopathol       Date:  1993-10       Impact factor: 1.533

5.  Tubular adenoma and syringocystadenoma papilliferum: a reappraisal of their relationship. An interobserver study of a series, by a panel of dermatopathologists.

Authors:  Dmitry V Kazakov; Michele Bisceglia; Eduardo Calonje; Markus Hantschke; Heinz Kutzner; Thomas Mentzel; Michal Michal; Petr Mukensnabl; Dominic V Spagnolo; Arno Rütten; Christian Rose; Carmelo Urso; Marina Vazmitel; Bernhard Zelger
Journal:  Am J Dermatopathol       Date:  2007-06       Impact factor: 1.533

6.  Tubular apocrine adenoma in association with syringocystadenoma papilliferum.

Authors:  Fatma Aktepe; Yavuz Demir; F Hüsniye Dilek
Journal:  Dermatol Online J       Date:  2003-02
  6 in total
  1 in total

1.  Neonatal syringocystadenoma papilliferum: A case report.

Authors:  Hong-Jing Jiang; Zhao Zhang; Li Zhang; Yun-Jing Pu; Nian Zhou; Hong Shu
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.